Circulating Tumor Cells (CTC) predict survival benefit from treatment in metastatic castration resistant prostate cancer (CRPC)

J.S. de Bono; H.I. Scher; R.B. Montgomery; C. Parker; M.C. Miller; H. Tissing; G.V. Doyle; Leonardus Wendelinus Mathias Marie Terstappen; K.J. Pienta; D. Raghavan

Circulating Tumor Cells (CTC) predict survival benefit from treatment in metastatic castration resistant prostate cancer (CRPC)

J.S. de Bono, H.I. Scher, R.B. Montgomery, C. Parker, M.C. Miller, H. Tissing, G.V. Doyle, Leonardus Wendelinus Mathias Marie Terstappen, K.J. Pienta, D. Raghavan

Research output: Contribution to journal › Article › Academic › peer-review

1951 Citations (Scopus)

Original language	Undefined
Pages (from-to)	6302-6309
Number of pages	8
Journal	Clinical cancer research
Volume	14
Publication status	Published - 2008

Keywords

METIS-251923

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{4d5d8bd310c24b929aaed8c98850c447,

title = "Circulating Tumor Cells (CTC) predict survival benefit from treatment in metastatic castration resistant prostate cancer (CRPC)",

keywords = "METIS-251923",

author = "{de Bono}, J.S. and H.I. Scher and R.B. Montgomery and C. Parker and M.C. Miller and H. Tissing and G.V. Doyle and Terstappen, {Leonardus Wendelinus Mathias Marie} and K.J. Pienta and D. Raghavan",

year = "2008",

language = "Undefined",

volume = "14",

pages = "6302--6309",

journal = "Clinical cancer research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

}

TY - JOUR

T1 - Circulating Tumor Cells (CTC) predict survival benefit from treatment in metastatic castration resistant prostate cancer (CRPC)

AU - de Bono, J.S.

AU - Scher, H.I.

AU - Montgomery, R.B.

AU - Parker, C.

AU - Miller, M.C.

AU - Tissing, H.

AU - Doyle, G.V.

AU - Terstappen, Leonardus Wendelinus Mathias Marie

AU - Pienta, K.J.

AU - Raghavan, D.

PY - 2008

Y1 - 2008

KW - METIS-251923

M3 - Article

SN - 1078-0432

VL - 14

SP - 6302

EP - 6309

JO - Clinical cancer research

JF - Clinical cancer research

ER -